Paradigm Biopharmaceuticals | PAR - Ebit

Stock Price
0.30
Daily Change
-0.02 -4.76%
Monthly
-18.92%
Yearly
-44.95%
Q1 Forecast
0.30

Paradigm Biopharmaceuticals reported AUD-19.93M in EBIT for its fiscal semester ending in June of 2023.





Ebit Change Date
Avita Medical AUD -8.66M 1.61M Jun/2025
Medical Developments International AUD -12.12M 3.97M Jun/2023
Neuren Pharmaceuticals AUD 171.1M 159.25M Dec/2024
Pacific Edge NZD -19.4M 2.91M Dec/2025
PYC Therapeutics AUD -25.84M 3M Dec/2024
Telix Pharmaceuticals AUD 37.44M 16.38M Dec/2024